Filing Analysis
Officer Departure
Filed Apr 06, 2026
LOW
On April 6, 2026, Gaurav Aggarwal resigned from the Board of Directors of Unicycive Therapeutics, Inc. The company reported that the departure was not due to any disagreements regarding operations, policies, or practices.
Key Facts
- Director Gaurav Aggarwal resigned effective April 6, 2026.
- The resignation was not the result of any disagreement with the Company, management, or the Board.
- The company is listed on the Nasdaq Capital Market under the symbol UNCY.
Regulation FD Disclosure
Filed Mar 30, 2026
LOW
Unicycive Therapeutics, Inc. reported its full-year 2025 financial results and provided a business update on March 30, 2026. The filing is a routine disclosure of annual performance via a furnished press release.
Key Facts
- Announced financial results for the full year ended December 31, 2025
- Press release issued and furnished on March 30, 2026
- Included a business update alongside the financial results
- The information is furnished under Item 2.02 and not considered 'filed' for liability purposes
Disclaimer: This analysis is generated by AI and is for informational purposes only.
It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities.
Always review the original SEC filings and consult a financial advisor before making investment decisions.